ENvue Medical, Inc. (FEED) Stock Analysis & Investment Frameworks
ENvue Medical, Inc. (FEED) stock analysis on Invetso. Review ENvue Medical, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
ENvue Medical, Inc. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Medical - Specialties
- Country: US
ENvue Medical, Inc. Key Financial Metrics
- Market Cap: $951429.00
- Revenue: $2.55M
- ROE: -60.47%
- ROIC: -45.89%
- Dividend Yield: N/A
About ENvue Medical, Inc.
NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span across several global markets, such as the United States, Europe, Australia, India, and Israel, in addition to other territories. This enterprise was founded by Harold Jacob and Jona Zumeris in September 2003, and its main corporate office is situated in Tyler, Texas.
ENvue Medical, Inc. Investment Frameworks
Invetso analyzes ENvue Medical, Inc. (FEED) across the following frameworks:
- ENvue Medical, Inc. 10Y Growth Potential
- ENvue Medical, Inc. Scenario Analysis
- ENvue Medical, Inc. Risks & Opportunities
- ENvue Medical, Inc. Economic Moat
- ENvue Medical, Inc. Business Model
- ENvue Medical, Inc. Management
- ENvue Medical, Inc. SWOT Analysis
- ENvue Medical, Inc. Porter's 5 Forces
- ENvue Medical, Inc. PESTLE Analysis
- ENvue Medical, Inc. ESG Analysis